Grants and Contributions:
Title:
2223-HQ-000215
Agreement Number:
2223-HQ-000215
Agreement Value:
-$237,995.00
Agreement Date:
Jul 1, 2022 - Mar 31, 2024
Description:
Not Available
Organization:
Public Health Agency of Canada
Expected Results:
Not Available
Location:
Calgary, Alberta, CA T2L 2K8
Reference Number:
1480-2022-2023-Qrt4-0000576
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
892538893
Recipient Type:
Other
Additional Information:
Restatement of Award: The total award value of $1,137,690.00 reported in a previous quarter has been reduced by this Amendment.
Amendment Date
Mar 31, 2023
Recipient's Legal Name:
Alberta Precision Laboratories Ltd.
Program:
Infectious Disease Prevention and Control
Program Purpose:
To protect Canadians from infectious diseases (e.g., Human Immunodeficiency Virus (HIV), E. Coli and measles) by predicting, detecting, assessing and responding to outbreaks and new threats, and contribute to the prevention, control and reduction of the spread of infectious disease among Canadians.
Amendments: